Barrington Research Downgrades Haemonetics (HAE) to Market Perform
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.41 +3.59%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 9
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 9
Join SI Premium – FREE
Barrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $43.80 yesterday.
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $43.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Haemonetics signs non-exclusive supply deal with CSL Plasma
- CLSA Downgrades Infosys Ltd. (INFO:IN) (INFY) to Hold (3)
- Macquarie Downgrades Kuaishou Technology (1024:HK) to Underperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
